Physician profile
Yang Qu
NPI 1205457900
$4,183.90
in general payments reported to CMS, 2019-2025
17 companies · $2,757 in 2025
The $2,757 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,427 · 2025: $2,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,009 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,009.31 |
| Education | $174.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,142.00 | 2024-2025 | |
| Janssen Biotech, INC. | $741.74 | 2024-2025 | Tremfya |
| Organon LLC | $594.35 | 2024-2025 | Hadlima, Vtama |
| Sun Pharmaceutical Industries INC. | $262.31 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $216.48 | 2024-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $200.61 | 2025 | Libtayo, Dupixent |
| Pfizer INC. | $196.55 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $151.81 | 2024 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $145.53 | 2024-2025 | |
| Ucb, INC. | $108.15 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $107.57 | 2024-2025 | |
| Lilly USA, LLC | $106.06 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Incyte Corporation | $72.23 | 2024-2025 | Opzelura |
| Galderma Laboratories, L.P. | $62.82 | 2025 | Nemluvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.29 | 2024 | Spevigo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $25.37 | 2025 | Xolair |
| Leo Pharma INC. | $22.03 | 2024 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yang Qu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.